褐色脂肪组织
产热
脂肪组织
葡萄糖稳态
背景(考古学)
内分泌学
化学
葡萄糖摄取
刺激
内科学
糖尿病
胰岛素抵抗
生物
胰岛素
生物化学
医学
古生物学
作者
Maria Grandoch,Ulrich Flögel,Sam Virtue,Julia K. Maier,Tomáš Jeleník,Christina Kohlmorgen,Kathrin Feldmann,Yanina Ostendorf,Tamara R. Castañeda,Zhou Zhou,Yu Yamaguchi,Emmani B. M. Nascimento,Vivekananda Gupta Sunkari,Christine Goy,Martina Kinzig,Fritz Sörgel,Paul L. Bollyky,Patrick Schrauwen,Hadi Al‐Hasani,Michael Roden
标识
DOI:10.1038/s42255-019-0055-6
摘要
Therapeutic increase of brown adipose tissue (BAT) thermogenesis is of great interest as BAT activation counteracts obesity and insulin resistance. Hyaluronan (HA) is a glycosaminoglycan, found in the extracellular matrix, which is synthesized by HA synthases (Has1/Has2/Has3) from sugar precursors and accumulates in diabetic conditions. Its synthesis can be inhibited by the small molecule 4-methylumbelliferone (4-MU). Here, we show that the inhibition of HA-synthesis by 4-MU or genetic deletion of Has2/Has3 improves BAT`s thermogenic capacity, reduces body weight gain, and improves glucose homeostasis independently from adrenergic stimulation in mice on diabetogenic diet, as shown by a magnetic resonance T2 mapping approach. Inhibition of HA synthesis increases glycolysis, BAT respiration and uncoupling protein 1 expression. In addition, we show that 4-MU increases BAT capacity without inducing chronic stimulation and propose that 4-MU, a clinically approved prescription-free drug, could be repurposed to treat obesity and diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI